| Literature DB >> 7669442 |
J Kalef-Ezra1, A Challa, N Chaliasos, I Hatzikonstantinou, I Papaefstathiou, V Cholevas, D Glaros, P Lapatsanis.
Abstract
Homozygous beta-thalassemia is a severe hereditary disorder associated with osteopenia. Recently it was suggested that thalassemia minor may be a risk factor for osteoporosis. The purpose of the present study was to investigate this suggestion. Bone mineral status was assessed in 22 premenopausal women and 21 men with beta-thalassemia minor. In vivo neutron activation analysis was applied to measure hand-bone phosphorus (HBP), single-photon absorptiometry to measure forearm bone mineral content (BMC), and dual-energy X-ray absorptiometry to measure spinal bone mineral density (BMD). Comparison of the HBP, BMC, and BMD values with those of sex- and age-matched healthy subjects without the beta-thalassemia trait failed to indicate a statistically significant difference for either sex group. Concerning the biochemical markers of bone metabolism that were studied (serum calcium, phosphate, alkaline phosphatase, osteocalcin, and parathyroid hormone, and 3-h fasting urine calcium-to-urine creatinine ratio) no difference was observed between the study subjects and matched controls. In conclusion, the present study showed that subjects with beta-thalassemia minor are not at risk for osteoporosis.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7669442 DOI: 10.1016/8756-3282(95)00117-v
Source DB: PubMed Journal: Bone ISSN: 1873-2763 Impact factor: 4.398